Diagnosis of AML is confirmed through a combination of bone marrow biopsy and peripheral blood smear examination. In the bone marrow biopsy, an increased percentage of blasts (greater than 20%) is a key diagnostic criterion. Cytogenetic and molecular analyses are also performed to identify specific genetic abnormalities associated with different subtypes of AML.